292 related articles for article (PubMed ID: 32745632)
1. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III.
Reja M; Makar M; Visaria A; Marino D; Rustgi V
Ann Hepatol; 2020; 19(6):635-640. PubMed ID: 32745632
[TBL] [Abstract][Full Text] [Related]
2. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
3. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
Wong RJ; Liu B; Bhuket T
Aliment Pharmacol Ther; 2017 Nov; 46(10):974-980. PubMed ID: 28914448
[TBL] [Abstract][Full Text] [Related]
4. Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016).
Reja D; Makar M; Visaria A; Karanfilian B; Rustgi V
Ann Hepatol; 2020; 19(4):404-410. PubMed ID: 32376236
[TBL] [Abstract][Full Text] [Related]
5. The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018.
Liu J; Tan L; Liu Z; Shi R
Ann Med; 2022 Dec; 54(1):2259-2268. PubMed ID: 35975984
[TBL] [Abstract][Full Text] [Related]
6. Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults.
Yang HH; Chen GC; Li DM; Lan L; Chen LH; Xu JY; Qin LQ
Sci Rep; 2021 May; 11(1):10387. PubMed ID: 34002001
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
9. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
[TBL] [Abstract][Full Text] [Related]
10. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
13. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.
Wang T; Xi Y; Raji A; Crutchlow M; Fernandes G; Engel SS; Zhang X
Ann Hepatol; 2024; 29(1):101154. PubMed ID: 37742743
[TBL] [Abstract][Full Text] [Related]
14. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
Liu CF; Chien LW
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
[TBL] [Abstract][Full Text] [Related]
15. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Kim MC; Lee JI; Kim JH; Kim HJ; Cho YK; Jeon WK; Kim BI; Sohn W
PLoS One; 2020; 15(10):e0240195. PubMed ID: 33095789
[TBL] [Abstract][Full Text] [Related]
16. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
[TBL] [Abstract][Full Text] [Related]
17. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
[TBL] [Abstract][Full Text] [Related]
18. Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.
Wang A; Lazo M; Carter HB; Groopman JD; Nelson WG; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1331-1338. PubMed ID: 31160348
[TBL] [Abstract][Full Text] [Related]
19. Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: Evidence from the NHANES database of the USA.
Zhao X; Shi X; Gu H; Zhou W; Zhang Q
J Gastroenterol Hepatol; 2023 Oct; 38(10):1734-1742. PubMed ID: 36805682
[TBL] [Abstract][Full Text] [Related]
20. Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
Jiang R; Zhou Y; Han L; Hong Z
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102228. PubMed ID: 37865224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
